Clinical trial Recruiting at 1 site Observational Ages 21 and up Women only

Comparing two surgical methods for pelvic organ prolapse treatment

Official title: A Prospective, Observational Trial of Transvaginal Uterine Suspension With the New Minimally Invasive Uterine Suspension

Run by National Cheng-Kung University Hospital · NCT05586984 · Data updated 2026-11-12

This study is testing two different surgical methods to see which one works better and is safer for women with pelvic organ prolapse who need surgery.

Quick facts

Study typeObservational
Ages21 Years and up
SexWomen only
Enrollment90 (estimated)
SponsorNational Cheng-Kung University Hospital
Academic / other
Locations1 site (Tainan)
StatusRecruiting
StartedJuly 26, 2022
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedOctober 21, 2022
Trial IDNCT05586984 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women over 21 years old with at least stage 2 uterine prolapse who are seeking uterus-preserving surgical options.

Probably not a fit

Patients who have had previous hysterectomies or surgeries for pelvic organ prolapse, or those with certain comorbidities, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the therapeutic efficacy and safety of laparoscopic uterine lateral suspension with transvaginal sacrospinous ligament fixation for treating pelvic organ prolapse. It focuses on patients who are dissatisfied with conservative treatments or have severe symptoms requiring surgical intervention. The trial aims to evaluate long-term outcomes, including safety and adverse events associated with both surgical approaches. By analyzing these methods, the study seeks to provide insights into the best practices for uterus-preserving surgeries.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical options for women suffering from pelvic organ prolapse, enhancing recovery times and reducing complications.

How similar studies have gone: While laparoscopic approaches have shown promise in other studies, this specific comparison of techniques is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* older than 21 years old.
* uterine prolapse stage 2 at least, defined by C point distal to -1cm by POP-Q system.
* patients willing to receive a uterine-preserving surgery for pelvic organ prolapse, and is suitable for anesthesia after evaluation.
* patients who had or had not received conservative treatments for pelvic organ prolapse.
* patients able and willing to finish the questionnaire evaluation.

Exclusion Criteria:

* patient who had received a previous hysterectomy, or is planning on concomitant hysterectomy in the surgery for pelvic organ prolapse.
* patient who had received a previous surgery for pelvic organ prolapse.
* patient with history of adverse events following a synthetic mesh.
* patients with chronic or acute pelvic pain.
* patients who had received abdominal or pelvic irradiation.
* patients who cannot receive either surgery due to comorbidity.
* patients pregnant or with future plan of pregnancy.
* patients with vaginal length less than 5cm.

Where it's running

  • National Cheng Kung University Hospital
    Tainan, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.